Relieve Depression News Today

“Our patients, our field, and our integrity demand a better explanation of what happened in STAR*D than what has thus been provided.”

Psychiatry’s depression outcomes are poor because its treatments are based on a depression model that science has flushed down the toilet.

A recent reanalysis of previously undisclosed data reveals that STAR*D may go down in US medical history as one of its most harmful scandals.

From a new look at the famous STAR*D study to updates from the National Academy of Sciences Conference on Adult ADHD, here are highlights from the week in Psychiatric Times.

Since 2006, STAR*D stands out as an icon guiding treatment decisions of major depressive disorder. But what if it is broken?

Objective To investigate the effectiveness of combining mirtazapine with serotonin-noradrenaline reuptake inhibitor (SNRI) or selective serotonin reuptake inhibitor (SSRI) antidepressants for treatment resistant depression in primary care. Design Two parallel group multicentre phase III randomised placebo controlled trial. Setting 106 general practices in four UK sites; Bristol, Exeter, Hull, and Keele/North Staffs, August 2013 to October 2015. Participants 480 adults aged 18 or more years who s...

The demand for mental health care in the United States is increasing, with more people seeking therapy and counseling. However, reports suggest that m

2009 report posted for filing Contact: Clare Collins CollCX@upmc.edu 412-647-3555 University of Pittsburgh Schools of the Health Sciences Are we cherry picking participants for studies of antidepressants? People with depression often excluded from clinical studies and tend not to fare as well as study participants PITTSBURGH, April 28 – Findings from clinical studies used to…

The association between treatment-resistant depression and uncommon functional genetic alleles.

This week, I wanted to see what ChatGPT would have to say about the long-term impact of antidepressants and about the STAR*D study.